Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ATSDR), 58557-58558 [2012-23392]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 184 / Friday, September 21, 2012 / Notices
1844(c)) and Section 10 of the Home
Owners Loan Act (12 U.S.C. 1467a(b)).
The FR Y–12 data are not considered
confidential, however, a BHC or SLHC
may request confidential treatment
pursuant to Sections (b)(4) of the
Freedom of Information Act (FOIA) (5
U.S.C. 552(b)(4)). The FR Y–12A data
are considered confidential pursuant to
sections (b)(4) and (b)(8) of the Freedom
of Information Act (5 U.S.C. 552(b)(4)
and (b)(8)).
Abstract: The FR Y–12 collects
information from certain domestic BHCs
and SLHCs on their equity investments
in nonfinancial companies on four
schedules: Type of Investments, Type of
Security, Type of Entity within the
Banking Organization, and Nonfinancial
Investment Transactions during
Reporting Period. The FR Y–12A
collects data from financial holding
companies (FHCs) which hold merchant
banking investments that are
approaching the end of the holding
period permissible under Regulation Y.
These data serve as an important riskmonitoring device for FHCs active in
this business line by allowing
supervisory staff to monitor an FHC’s
activity between review dates. They also
serve as an early warning mechanism to
identify FHCs whose activities in this
area are growing rapidly and therefore
warrant special supervisory attention.
Board of Governors of the Federal Reserve
System, September 17, 2012.
Robert deV. Frierson,
Secretary of the Board.
[FR Doc. 2012–23268 Filed 9–20–12; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Council on
Alzheimer’s Research, Care, and
Services
Assistant Secretary for
Planning and Evaluation, HHS.
ACTION: Notice of meeting.
This notice announces the
public meeting of the Advisory Council
on Alzheimer’s Research, Care, and
Services (Advisory Council). Notice of
these meetings is given under the
Federal Advisory Committee Act (5
U.S.C. App. 2, section 10(a)(1) and
(a)(2)). The Advisory Council on
Alzheimer’s Research, Care, and
Services provides advice on how to
prevent or reduce the burden of
Alzheimer’s disease and related
dementias on people with the disease
and their caregivers. The Advisory
Council will discuss recommendations
pmangrum on DSK3VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:05 Sep 20, 2012
Jkt 226001
made in May, as well as ideas and
topics for future recommendations.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting Date: October 15, 2012
from 9 a.m. to 4:30pm EDT.
Centers for Disease Control and
Prevention
DATES:
The meeting will be held at
the U.S. Department of Health and
Human Services, 200 Independence
Avenue SW., Room 800, Washington,
DC 20201.
Comments: Time is allocated on the
agenda to hear public comments. In lieu
of oral comments, formal written
comments may be submitted for the
record to Helen Lamont, Ph.D., OASPE,
200 Independence Avenue SW., Room
424E, Washington, DC 20201.
Comments may also be sent to
napa@hhs.gov. Those submitting
written comments should identify
themselves and any relevant
organizational affiliations.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Helen Lamont, Ph.D. (202) 690–7996,
Helen.lamont@hhs.gov. Note: Seating
may be limited. Those wishing to attend
the meeting must send an email to
napa@hhs.gov and put ‘‘October 15
meeting attendance’’ in the Subject line
by Friday, October 5, 2012, so that their
names may be put on a list of expected
attendees and forwarded to the security
officers at the Department of Health and
Human Services. Attendees who wish to
make public comments should include
that information in the email. Any
interested member of the public who is
a non-U.S. citizen should include this
information at the time of registration to
ensure that the appropriate security
procedure to gain entry to the building
is carried out. Although the meeting is
open to the public, procedures
governing security and the entrance to
Federal buildings may change without
notice.
Topics of
the Meeting: The Advisory Council will
discuss recommendations made in May,
as well as ideas and topics for future
recommendations.
Procedure and Agenda: This meeting
is open to the public.
SUPPLEMENTARY INFORMATION:
AGENCY:
58557
Authority: 42 U.S.C. 11225; Section 2(e)(3)
of the National Alzheimer’s Project Act. The
panel is governed by provisions of Public
Law 92–463, as amended (5 U.S.C. Appendix
2), which sets forth standards for the
formation and use of advisory committees.
Dated: September 14, 2012.
Donald Moulds,
Acting Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2012–23391 Filed 9–20–12; 8:45 am]
BILLING CODE P
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 8:30 a.m.–4 p.m.,
October 16, 2012; 8:30 a.m.–11:30 a.m.,
October 17, 2012.
Place: CDC, 4770 Buford Highway, Atlanta,
Georgia 30341.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 75 people.
Purpose: The Secretary, Department of
Health and Human Services (HHS) and by
delegation, the Director, CDC and
Administrator, NCEH/ATSDR, are authorized
under Section 301(42 U.S.C. 241) and Section
311(42 U.S.C. 243) of the Public Health
Service Act, as amended, to: (1) Conduct,
encourage, cooperate with, and assist other
appropriate public authorities, scientific
institutions, and scientists in the conduct of
research, investigations, experiments,
demonstrations, and studies relating to the
causes, diagnosis, treatment, control, and
prevention of physical and mental diseases
and other impairments; (2) assist states and
their political subdivisions in the prevention
of infectious diseases and other preventable
conditions and in the promotion of health
and well being; and (3) train state and local
personnel in health work. The BSC, NCEH/
ATSDR provides advice and guidance to the
Secretary, HHS; the Director, CDC and
Administrator, ATSDR; and the Director,
NCEH/ATSDR, regarding program goals,
objectives, strategies, and priorities in
fulfillment of the agency’s mission to protect
and promote people’s health. The board
provides advice and guidance that will assist
NCEH/ATSDR in ensuring scientific quality,
timeliness, utility, and dissemination of
results. The board also provides guidance to
help NCEH/ATSDR work more efficiently
and effectively with its various constituents
and to fulfill its mission in protecting
America’s health.
Matters To Be Discussed: The agenda items
for the BSC Meeting on October 16–17, 2012,
will include NCEH/ATSDR Office of the
Director updates: ATSDR Reorganization,
Asthma, Lead and Healthy Homes Program
and NCEH/ATSDR Strategic Planning;
update on the Lead Program; presentation on
surveillance and epidemiology after
emergency events; and updates by BSC
Federal Expert members on current activities
at the National Institute for Occupational
Safety and Health, U.S. Department of
Energy, National Institute for Environmental
E:\FR\FM\21SEN1.SGM
21SEN1
58558
Federal Register / Vol. 77, No. 184 / Friday, September 21, 2012 / Notices
Health Services and the U.S. Environmental
Protection Agency.
Agenda items are subject to change as
priorities dictate.
Supplementary Information: The public
comment period is scheduled on Tuesday,
October 16, 2012, from 3:15 p.m. until 3:30
p.m., and on Wednesday, October 17, 2012,
from 10 a.m. until 10:15 a.m.
Contact Person for More Information:
Sandra Malcom, Committee Management
Specialist, NCEH/ATSDR, CDC, 4770 Buford
Highway, Mail Stop F–61, Chamblee, Georgia
30345; telephone 770/488–0575, Fax: 770/
488–3377; Email: smalcom@cdc.gov. The
deadline for notification of attendance is
October 12, 2012.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: September 17, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2012–23392 Filed 9–20–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–2567, CMS–
10425, CMS–10417, CMS–10428, CMS–1500
(02/12), and CMS–1500 (08/05)]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
pmangrum on DSK3VPTVN1PROD with NOTICES
AGENCY:
VerDate Mar<15>2010
15:05 Sep 20, 2012
Jkt 226001
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension without change of a
currently approved collection. Title of
Information Collection: Deficiencies and
Plan of Correction (CMS–2567) and
Supporting Regulations contained in 42
CFR 488.18, 488.26, and 488.28. Use:
Section 1864(a) of the Social Security
Act requires that the Secretary use state
survey agencies to conduct surveys to
determine whether health care facilities
meet Medicare and Clinical Laboratory
Improvement Amendments
participation requirements. The CMS–
2567 form is the means by which the
survey findings are documented. This
section of the law further requires that
compliance findings resulting from
these surveys be made available to the
public within 90 days of such surveys.
The CMS–2567 form is the vehicle for
this disclosure. The regulations at 42
CFR 488.18 require that state survey
agencies document all deficiency
findings on a statement of deficiencies
and plan of correction, which is the
CMS–2567. 42 CFR 488.26 and 488.28
further delineate how compliance
findings must be recorded and that CMS
prescribed forms must be used.
The form is also used by health care
facilities to document their plan of
correction and by CMS, the states,
facilities, purchasers, consumers,
advocacy groups, and the public as a
source of information about quality of
care and facility compliance.
Form Number: CMS–2567 (OCN
0938–0391). Frequency: Yearly and
occasionally. Affected Public: Private
Sector (Business or other for-profit and
not-for-profit institutions). Number of
Respondents: 62,000. Total Annual
Responses: 62,000. Total Annual Hours:
134,540. (For policy questions regarding
this collection contact Angela MasonElbert at 410–786–8279. For all other
issues call 410–786–1326.)
2. Type of Information Collection
Request: New collection; Title of
Information Collection: Evaluation of
Patient Satisfaction and Experience of
Care for Medicare Beneficiaries with
End-Stage Renal Disease (ESRD): Impact
of the ESRD Prospective Payment
System (PPS) and ESRD Quality
Incentive Program (QIP) ; Use: The
Medicare Prescription Drug
Improvement, and Modernization Act of
2003 (MMA) required the Secretary of
Health and Human Services (HHS) to
submit to Congress a report detailing the
elements and features for the design and
implementation of a bundled End-Stage
Renal Disease Prospective Payment
System, specifying that such a system
should include the bundling of
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
separately billed drugs, clinical
laboratory tests, and other items ‘‘to
maximum extent feasible’’. The
Medicare Improvements for Patients and
Providers Act of 2008 (MIPPA) directed
the Secretary of HHS to implement a
payment system under which a single
payment is made to a provider of
services or a renal dialysis facility for
renal dialysis services in lieu of any
other payment. The ESRD PPS combines
composite rate dialysis services with
separately billable services under a
single payment adjusted to reflect
patient differences in resource needs or
case-mix. The MIPPA also stipulated the
development of quality incentives for
the ESRD program. CMS has established
the End-Stage Renal Disease Quality
Incentive Program (ESRD QIP) to
address this provision of the legislation.
In order to assess the impact of the
final rule (76 FR 627) on ESRD
beneficiary experiences, satisfaction,
and health outcomes, CMS is requesting
OMB approval to obtain input on the
effect of the final rule on our ESRD
beneficiaries. The purpose of this data
collection effort is to assess beneficiary
satisfaction and experience of care in
terms of access to services, quality of
care, outcomes, and cost. This will be
measured through telephone surveys
with ESRD beneficiaries and through
interviews with key stakeholders in the
renal health care community. The
information obtained from both the
beneficiary respondents and key
stakeholders will be used to provide an
initial reporting of the ESRD PPS/QIP’s
effects on beneficiary satisfaction and
experience of care and to inform the
Centers for Medicare & Medicaid
Services (CMS) of the impact of the
ESRD PPS/QIP on patient satisfaction
and experience of care, including
unintended consequences, for
consideration of future modification of
the programs.
Subsequent to the publication of the
60-day Federal Register notice (77 FR
27777), the annual burden hours have
decreased from 1,287 to 662. Early
cognitive interview findings of the
ESRD Beneficiary Survey submitted
during the 60 day notice exhibited
respondent complaints that the survey
was too long and some participants had
to hang up early because they were
feeling sick. Medicare beneficiaries with
end stage renal disease (ESRD) are very
sick and unable to remain cognitively
aware for 30 minutes. The ESRD
Beneficiary Survey was significantly
shortened so that the time necessary to
interview a single participant was
reduced from 30 to 15 minutes. Form
Number: CMS–10425 (OCN: 0938–
New); Frequency: Yearly; Affected
E:\FR\FM\21SEN1.SGM
21SEN1
]]>Agencies
[Federal Register Volume 77, Number 184 (Friday, September 21, 2012)]
[Notices]
[Pages 58557-58558]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-23392]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Environmental
Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/
ATSDR)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Times and Dates: 8:30 a.m.-4 p.m., October 16, 2012; 8:30 a.m.-
11:30 a.m., October 17, 2012.
Place: CDC, 4770 Buford Highway, Atlanta, Georgia 30341.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 75 people.
Purpose: The Secretary, Department of Health and Human Services
(HHS) and by delegation, the Director, CDC and Administrator, NCEH/
ATSDR, are authorized under Section 301(42 U.S.C. 241) and Section
311(42 U.S.C. 243) of the Public Health Service Act, as amended, to:
(1) Conduct, encourage, cooperate with, and assist other appropriate
public authorities, scientific institutions, and scientists in the
conduct of research, investigations, experiments, demonstrations,
and studies relating to the causes, diagnosis, treatment, control,
and prevention of physical and mental diseases and other
impairments; (2) assist states and their political subdivisions in
the prevention of infectious diseases and other preventable
conditions and in the promotion of health and well being; and (3)
train state and local personnel in health work. The BSC, NCEH/ATSDR
provides advice and guidance to the Secretary, HHS; the Director,
CDC and Administrator, ATSDR; and the Director, NCEH/ATSDR,
regarding program goals, objectives, strategies, and priorities in
fulfillment of the agency's mission to protect and promote people's
health. The board provides advice and guidance that will assist
NCEH/ATSDR in ensuring scientific quality, timeliness, utility, and
dissemination of results. The board also provides guidance to help
NCEH/ATSDR work more efficiently and effectively with its various
constituents and to fulfill its mission in protecting America's
health.
Matters To Be Discussed: The agenda items for the BSC Meeting on
October 16-17, 2012, will include NCEH/ATSDR Office of the Director
updates: ATSDR Reorganization, Asthma, Lead and Healthy Homes
Program and NCEH/ATSDR Strategic Planning; update on the Lead
Program; presentation on surveillance and epidemiology after
emergency events; and updates by BSC Federal Expert members on
current activities at the National Institute for Occupational Safety
and Health, U.S. Department of Energy, National Institute for
Environmental
[[Page 58558]]
Health Services and the U.S. Environmental Protection Agency.
Agenda items are subject to change as priorities dictate.
Supplementary Information: The public comment period is
scheduled on Tuesday, October 16, 2012, from 3:15 p.m. until 3:30
p.m., and on Wednesday, October 17, 2012, from 10 a.m. until 10:15
a.m.
Contact Person for More Information: Sandra Malcom, Committee
Management Specialist, NCEH/ATSDR, CDC, 4770 Buford Highway, Mail
Stop F-61, Chamblee, Georgia 30345; telephone 770/488-0575, Fax:
770/488-3377; Email: smalcom@cdc.gov. The deadline for notification
of attendance is October 12, 2012.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: September 17, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 2012-23392 Filed 9-20-12; 8:45 am]
BILLING CODE 4163-18-P
